These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34657137)

  • 1. Effect of febuxostat on left ventricular diastolic function in patients with asymptomatic hyperuricemia: a sub analysis of the PRIZE Study.
    Kusunose K; Yoshida H; Tanaka A; Teragawa H; Akasaki Y; Fukumoto Y; Eguchi K; Kamiya H; Kario K; Yamada H; Sata M; Node K;
    Hypertens Res; 2022 Jan; 45(1):106-115. PubMed ID: 34657137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study.
    Yamada H; Tanaka A; Kusunose K; Amano R; Matsuhisa M; Daida H; Ito M; Tsutsui H; Nanasato M; Kamiya H; Bando YK; Odawara M; Yoshida H; Murohara T; Sata M; Node K;
    Cardiovasc Diabetol; 2017 May; 16(1):63. PubMed ID: 28490337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients.
    Ceyhan C; Unal S; Yenisey C; Tekten T; Ceyhan FB
    Int J Cardiovasc Imaging; 2008 Mar; 24(3):253-9. PubMed ID: 17687631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between long-term prescription of febuxostat and the progression of heart failure with preserved ejection fraction in patients with hypertension and asymptomatic hyperuricemia.
    Pan JA; Lin H; Wang CQ; Zhang JF; Gu J
    Heart Vessels; 2020 Oct; 35(10):1446-1453. PubMed ID: 32430700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of canagliflozin on NT-proBNP stratified by left ventricular diastolic function in patients with type 2 diabetes and chronic heart failure: a sub analysis of the CANDLE trial.
    Kusunose K; Imai T; Tanaka A; Dohi K; Shiina K; Yamada T; Kida K; Eguchi K; Teragawa H; Takeishi Y; Ohte N; Yamada H; Sata M; Node K;
    Cardiovasc Diabetol; 2021 Sep; 20(1):186. PubMed ID: 34521417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial.
    Tanaka A; Taguchi I; Teragawa H; Ishizaka N; Kanzaki Y; Tomiyama H; Sata M; Sezai A; Eguchi K; Kato T; Toyoda S; Ishibashi R; Kario K; Ishizu T; Ueda S; Maemura K; Higashi Y; Yamada H; Ohishi M; Yokote K; Murohara T; Oyama JI; Node K;
    PLoS Med; 2020 Apr; 17(4):e1003095. PubMed ID: 32320401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostication of valvular aortic stenosis using tissue Doppler echocardiography: underappreciated importance of late diastolic mitral annular velocity.
    Poh KK; Chan MY; Yang H; Yong QW; Chan YH; Ling LH
    J Am Soc Echocardiogr; 2008 May; 21(5):475-81. PubMed ID: 17928192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The diagnostic value of N-terminal B-type natriuretic peptide in diastolic heart failure: comparison with echocardiographic findings].
    Tuğcu A; Yildirimtürk O; Aytekin S
    Turk Kardiyol Dern Ars; 2009 Mar; 37(2):112-21. PubMed ID: 19404033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of N-terminal pro-B-type natriuretic peptide with diastolic function in hypertensive heart disease.
    Uraizee I; Cheng S; Hung CL; Verma A; Thomas JD; Zile MR; Aurigemma GP; Solomon SD
    Am J Hypertens; 2013 Oct; 26(10):1234-41. PubMed ID: 23792241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial Stiffness and Indices of Left Ventricular Diastolic Dysfunction in Patients with Embolic Stroke of Undetermined Etiology.
    Gąsiorek P; Sakowicz A; Banach M; von Haehling S; Bielecka-Dabrowa A
    Dis Markers; 2019; 2019():9636197. PubMed ID: 31612072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of L- and N-type calcium channel blocker on uric acid levels and left atrial volume in hypertensive patients.
    Masaki M; Mano T; Eguchi A; Fujiwara S; Sugahara M; Hirotani S; Tsujino T; Komamura K; Koshiba M; Masuyama T
    Heart Vessels; 2016 Nov; 31(11):1826-1833. PubMed ID: 26825736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triphasic mitral inflow velocity with mid-diastolic flow: the presence of mid-diastolic mitral annular velocity indicates advanced diastolic dysfunction.
    Ha JW; Ahn JA; Moon JY; Suh HS; Kang SM; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY
    Eur J Echocardiogr; 2006 Jan; 7(1):16-21. PubMed ID: 16378917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of a xanthine oxidase inhibitor on arterial stiffness and carotid atherosclerosis: a subanalysis of the PRIZE study.
    Shiina K; Tomiyama H; Tanaka A; Yoshida H; Eguchi K; Kario K; Kato T; Teragawa H; Toyoda S; Ohishi M; Fukumoto Y; Takase B; Ishizu T; Node K;
    Hypertens Res; 2022 Apr; 45(4):602-611. PubMed ID: 35169280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of N-terminal pro-brain natriuretic peptide in the evaluation of postoperative left ventricular diastolic dysfunction.
    Islamoglu F; Ozcan K; Apaydin AZ; Soydas C; Bayindir O; Durmaz I
    Tex Heart Inst J; 2008; 35(2):111-8. PubMed ID: 18612440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular diastolic function assessment by tissue Doppler echocardiography in relation to hormonal replacement therapy in postmenopausal women with diastolic dysfunction.
    Gökçe M; Karahan B; Erdöl C; Kasap H; Ozdemirci S
    Am J Ther; 2003; 10(2):104-11. PubMed ID: 12629588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Trial of Effect of Urate-Lowering Agent Febuxostat in Chronic Heart Failure Patients with Hyperuricemia (LEAF-CHF).
    Yokota T; Fukushima A; Kinugawa S; Okumura T; Murohara T; Tsutsui H
    Int Heart J; 2018 Sep; 59(5):976-982. PubMed ID: 30101851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum N-terminal pro-B-type natriuretic peptide and left ventricle diastolic dysfunction in patients with hepatitis C virus infection.
    Che W; Liu W; Wei Y; Xu Y; Hou L; Matsumori A; Hu D
    J Viral Hepat; 2012 May; 19(5):327-31. PubMed ID: 22497811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-B-type natriuretic peptide and diastolic function measurements by adenosine stress echocardiography in prediction of coronary stenosis in patients.
    Zheng P; Wang H; Tian YQ; Guo YL; He ZX; Lu Y; Zheng X; Ma WJ; Xu N; Sun X; Zhang L
    Chin Med J (Engl); 2011 Jul; 124(14):2089-95. PubMed ID: 21933607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Diastolic Dysfunction with N-terminal Pro-B-type Natriuretic Peptide Level in Heart Failure Patients with Preserved Ejection Fraction.
    Islam MN; Chowdhury MS; Paul GK; Debnath RC; Shakil SS
    Mymensingh Med J; 2019 Apr; 28(2):333-346. PubMed ID: 31086148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.